New Evidence on the Impact of Cervical Cancer Screening and Treatment Using HPV DNA Tests, Visual Inspection or Cytology
Further, screening tests are only one component of a secondary-prevention program — neither VIA, Pap nor HPV testing can prevent disease unless followed by effective and timely treatment of precancerous lesions or invasive cervical cancer as indicated. Such programs require strong and consistent program leadership and management.
ACCP will regularly review new findings related to cervical cancer prevention and provide guidance on strategies and technologies that are most feasible and effective in low-resource settings. This will include how to design efficient screening programs for the future when large cohorts of women will have been vaccinated against HPV.
For more information, please visit the ACCP Web site: www.allianc e-cxca.org
Copyright © 1997-2009 National Cervical Cancer Coalition
The National Cervical Cancer Coalition and the National HPV Cancer Coalition are trademarks of the National Cervical Cancer Coalition.
Link to article: http://www.nccc-online.org/documents/ACCP_screening_factsheet_July09.pdf
Add A New CommentWe value and respect the experiences of all of our HerWriters, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice although we hope you can gain knowledge from their insight.
Add A New CommentComments
There are no comments yet. Be the first to get the conversation started.